Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection

J F Tsai1, H S Margolis, J E Jeng

  • 1Department of Internal Medicine, Kaohsiung Medical College, Taiwan.

Insights

Circulating immune complexes (CIC) are more frequent in patients with chronic hepatitis B and C dual infection. In chronic hepatitis C, elevated CIC correlate with more severe liver damage, suggesting a role in disease progression.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Circulating immune complexes (CIC) are implicated in viral hepatitis pathogenesis, potentially influencing tissue damage and viral clearance.
  • Understanding the role of CIC in chronic hepatitis B (CHB) and hepatitis C (HCV) is crucial for elucidating disease mechanisms.

Purpose of the Study:

  • To investigate the frequency of raised CIC in patients with CHB, chronic hepatitis C (CHC), and dual HBV/HCV infection.
  • To determine the association between specific CIC types and disease severity in chronic viral hepatitis.

Main Methods:

  • CIC levels (IgM, IgG, HBsAg-containing) were measured using conglutinin (K) and C1q assays.
  • Study included 101 patients with CHB, 48 with CHC, 24 with dual infection, and 54 healthy controls.

Main Results:

  • Patients with dual HBV/HCV infection showed significantly higher frequencies of raised IgM-C1q CIC (P < 0.001) and IgM-K CIC (P < 0.01) compared to CHB patients.
  • No significant difference in HBsAg-CIC prevalence was observed between CHB and dual infection groups.
  • In CHC patients, conglutinin-binding CIC were predominant and correlated with more severe liver damage.

Conclusions:

  • CIC play a significant role in the pathogenesis of chronic hepatitis C virus infection.
  • Elevated CIC, particularly IgM-based, are more common in dual hepatitis B and C infections.
  • The presence of certain CIC types may serve as a biomarker for liver damage severity in chronic hepatitis C.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...